September 1, 2015

Micronized Cellular Adipose Matrix as a Therapeutic Injectable for Diabetic Ulcer

Key Points

Key points are not available for this paper at this time.

Abstract

The proven potential of MCAM to accelerate healing in ischemic diabetic ulcers may offer a simple, safe and minimally invasive means for tissue repair and revitalization.

Ask AI

Helpful

Bookmark

Ask AI

Helpful

Bookmark

Cite This Study

Feng et al. (Tue,) studied this question.

synapsesocial.com/papers/69dfee136324afb55d593104 https://doi.org/https://doi.org/10.2217/rme.15.48

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rehabilitation of Irradiated Head and Neck Tissues by Autologous Fat Transplantation2009 · 151 citations
2Acellular adipose matrix as a natural scaffold for tissue engineering2013 · 49 citations
3Injectable Tissue-Engineered Bone Using Autogenous Bone Marrow–Derived Stromal Cells for Maxillary Sinus Augmentation: Clinical Application Report from a 2–6-Year Follow-Up2008 · 135 citations
4The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: A pilot study2010 · 140 citations
5The Effect of Human Adipose-Derived Stem Cells on Healing of Ischemic Wounds in a Diabetic Nude Mouse Model2011 · 87 citations